DBV Technologies to Present Data Further Supporting the Use of Epicutaneous Immunotherapy for the Treatment of Peanut Allergy at the 2018 ACAAI Meeting

… : DBV – ISIN: FR0010417345 – Nasdaq Stock Market: DBVT), a clinical-stage biopharmaceutical company … share) are traded on the Nasdaq Global Select Market (Ticker: DBVT …

Read More Here...

Bookmark the permalink.